The Impact of Pharmacist Discharge Medication Reconciliation on Unintentional Medication Discrepancies From Inpatient Discharges at the Alberta Cancer Board Cross Cancer Institute
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Alberta Health services
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- MRS Correlation with Treatment Response.
Study Overview
Brief Summary
Adverse drug events can occur commonly due to medication errors during the transition of care in a health care facility. Medication reconciliation is the process of comparing medications and providing an accurate medication list as a resource for prescribers, which is currently only being done upon inpatient admission at the CCI. The purpose of this study is to see if pharmacist medication reconciliation at discharge reduces unintentional medication discrepancies for inpatient discharges.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Cancer inpatients under the care of Dr. Follett or Dr. Candler
- •Cancer inpatients to be discharged from the CCI
- •Patients >18 years of age
- •Patients that are taking >1 medications or herbals total at home.
Exclusion Criteria
- •Cancer inpatients that are considered radioactive or in "hot rooms" (ie. Selectron patients or patients receiving radiation treatment for thyroid)
- •Patients that do not remain in hospital >72 hours
- •Patients without a home phone number or equivalent contact number.
- •Language barrier (patients unable to speak or understand English).
- •Patients that are readmitted and already included into the study.
Outcomes
Primary Outcomes
MRS Correlation with Treatment Response.
Time Frame: up to 1 year
The percentage of patients with at least one unintentional medication discrepancy after discharge from the Cross Cancer Institute
Secondary Outcomes
- Correlation with Tumor Stage(up to 1 year)
- The frequency of each type of unintentional medication discrepancies.
